| 000112 (2019) |
Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France] | Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study |
| 000219 (2017-11-03) |
Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Thomas Bardin [France] ; Alain Cantagrel [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Elodie Perrodeau [France] ; Philippe Ravaud [France] ; Xavier Mariette [France] | Corticosteroid Sparing Effect of Non-TNF Targeted Biologics, Rituximab, Abatacept and Tocilizumab in Common Practice: Data from 3183 Patients Enrolled in the French Society of Rheumatology Registries |
| 000363 (2016) |
Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France] | Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study |
| 000440 (2014) |
P. Emery [Royaume-Uni] ; J E Gottenberg [France] ; A. Rubbert-Roth [Allemagne] ; P. Sarzi-Puttini [Italie] ; D. Choquette [Canada] ; V M Martínez Taboada [Espagne] ; L. Barile-Fabris [Mexique] ; R J Moots [Royaume-Uni] ; A. Ostor [Royaume-Uni] ; A. Andrianakos [Grèce] ; E. Gemmen [États-Unis] ; C. Mpofu [Suisse] ; C. Chung [États-Unis] ; L Hinsch Gylvin [Suisse] ; A. Finckh [Suisse] | Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study |
| 000560 (2013) |
M. Schiff [États-Unis] ; M. Dougados [France] ; R. Fleischmann [États-Unis] ; J. Fay [États-Unis] ; M. Maldonado [États-Unis] | FRI0257 Abatacept and anti-tnf monoclonal antibodies: efficacy and safety comparisons |
| 000561 (2013) |
J. Sellam [France] ; S. Rouanet ; H. Hendel-Chavez ; S. Marion-Thore [France] ; C. Miceli-Richard ; B. Combe [France] ; J. Sibilia [France] ; X. Le Loët ; J. Tebib ; G. Chiocchia [France] ; R. Jourdan ; M. Dougados [France] ; Y. Taoufik ; X. Mariette | FRI0247 Serum level of interleukin 33, a novel independent predictive biomarker of clinical response to rituximab in rheumatoid arthritis: results from the smart trial |
| 000562 (2013) |
J. H. Salmon ; P. Ravaud [France] ; T. Bardin ; P. Cacoub [France] ; A. Cantagruel [France] ; B. Combe [France] ; M. Dougados [France] ; R.-M. Flipo ; B. Godeau ; L. Guillevin [France] ; X. Le Loët ; E. Hachulla ; T. Schaeverbeke ; J. Sibilia [France] ; I. Pane [France] ; G. Baron ; X. Mariette [France] ; J.-E. Gottenberg [France] | FRI0246 Serious infusion-related reactions after rituximab in patients with rheumatoid arthritis: data from the autoimmunity and rituximab registry |
| 000566 (2013) |
E. M. Vital [Royaume-Uni] ; L. Israelsson [Suède] ; L. Nogueira [France] ; V. Malmström [Suède] ; Y. El-Sherbiny [Royaume-Uni] ; A. Rawstron [Royaume-Uni] ; G. Serre [France] ; L. Klareskog [Suède] ; F. Ponchel [Royaume-Uni] ; P. Emery [Royaume-Uni] | FRI0227 Acpa fine specificity is associated with increased plasmablast numbers and worse clinical response to rituximab in rheumatoid arthritis |
| 000568 (2013) |
A.-P. Trouvin ; S. Jacquot ; S. Grigioni ; H. Boulard ; I. Dutot ; O. Vittecoq ; X. Le Loet ; O. Boyer ; V. Goeb [France] | FRI0215 Transitional and memory b cell analysis is an essential tool to anticipate clinical relapse in rheumatoid arthritis (RA) patients treated with rituximab |
| 000571 (2013) |
E. Keystone [Canada] ; S. B. Cohen [États-Unis] ; P. Emery [Royaume-Uni] ; J. M. Kremer [États-Unis] ; M. Dougados [France] ; J. E. Loveless ; C. Chung [États-Unis] ; P. Wong [États-Unis] ; P. B. Lehane [Royaume-Uni] ; H. Tyrrell [Royaume-Uni] | FRI0183 Sustained inhibition of structural damage in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors prior to rituximab treatment: 5-year data from the reflex study |
| 000572 (2013) |
A. Östör [Royaume-Uni] ; J. A. Román Ivorra [Espagne] ; J. Wollenhaupt [Allemagne] ; C. Mpofu [Suisse] ; C. Bernasconi [Suisse] ; J. Sibilia [France] ; V. Bykerk [États-Unis, Canada] | FRI0179 Comparison of tocilizumab as monotherapy or in combination with non-biological disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) and an inadequate response to anti-TNF agents |
| 000582 (2013) |
J.-E. Gottenberg [France] ; C. Mpofu [Suisse] ; W. Bensen [Canada] ; A. Rubbert-Roth [Allemagne] ; F. Irazoque [Mexique] ; V. Martínez Taboada [Espagne] ; C. Chung [États-Unis] ; L. Hinsch-Gylvin [Suisse] ; C. Ferri [Italie] ; P. Emery [Royaume-Uni] | AB0541 Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study |
| 000586 (2013) |
B. Combe [France] ; M. Dougados [France] ; I. Logeart ; C. Lukas [France] ; X. Mariette [France] ; X. Puechal ; A. Saraux ; T. Schaeverbeke [France] | AB0516 An open-label randomized controlled study to evaluate the efficacy of etanercept (ETN) versus rituximab (RTX), in patients with active rheumatoid arthritis previously treated with RTX and TNF blockers |
| 000034 (2020) |
Gaëlle Vial [France] ; Anaïs De Pouilly [France] ; Laetitia Scouppe [France] ; Bruno Pereira [France] ; Claire Daien [France] ; Cédric Lukas [France] ; Adeline Ruyssen-Witrand [France] ; Pascale Vergne-Salle [France] ; Christophe Richez [France] ; Anne Tournadre [France] | Factors influencing the choice of biologic therapy following Rituximab in patients with rheumatoid arthritis: A retrospective study using propensity score. |
| 000070 (2019) |
Souraya Sayegh [France, Liban] ; Oula El Atat [Liban] ; Katy Diallo [France] ; Benjamin Rauwel [France] ; Yannick Degboé [France] ; Etienne Cavaignac [France] ; Arnaud Constantin [France] ; Alain Cantagrel [France] ; Viviane Trak-Smayra [Liban] ; Nada Alaaeddine [Liban] ; Jean-Luc Davignon [France] | Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism |
| 000076 (2019) |
Yannick Degboé [France] ; Benjamin Rauwel [France] ; Michel Baron [France] ; Jean-Frédéric Boyer [France] ; Adeline Ruyssen-Witrand [France] ; Arnaud Constantin [France] ; Jean-Luc Davignon [France] | Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism |
| 000083 (2019) |
Audrey Paoletti [France] ; Julien Rohmer [France] ; Bineta Ly [France] ; Juliette Pascaud [France] ; Elodie Rivière [France] ; Raphaele Seror [France] ; Benoit Le Goff [France] ; Gaetane Nocturne [France] ; Xavier Mariette [France] | Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors |
| 000091 (2019) |
Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France] | Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice. |
| 000121 (2019) |
Josette Biya ; Sandra Dury ; Jeanne-Marie Perotin [France] ; Claire Launois ; Maxime Dewolf ; Gaëtan Deslée [France] ; François Lebargy | Assessment of TNF-α inhibitors in airway involvement of relapsing polychondritis |
| 000160 (2018) |
Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France] | Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data. |
| 000181 (2018) |
Damien Biotti [France] ; Fleur Lerebours [France] ; Fabrice Bonneville [France] ; Jonathan Ciron [France] ; Michel Clanet [France] ; David Brassat [France] | Late-onset neutropenia and neurological relapse, during long-term rituximab therapy in myelin oligodendrocyte glycoprotein-antibody spectrum disorder. |
| 000190 (2018) |
Cem Gabay [Suisse] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Caroline Paccard [France] ; Yong Lin [États-Unis] ; Neil M H. Graham [États-Unis] ; Anita Boyapati [États-Unis] | Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study |
| 000239 (2017) |
Johanna Sigaux [France] ; Florian Bailly [France] ; David Hajage [France] ; Xavier Mariette [France] ; Jacques Morel [France] ; Frédérique Gandjbakhch [France] ; Violaine Foltz [France] ; Laure Gossec [France] ; Florence Tubach [France] ; Bruno Fautrel [France] | Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial |
| 000263 (2017) |
Xavier Guillot [France] ; Hélène Martin [France] ; Stéphanie Seguin-Py [France] ; Katy Maguin-Gaté [France] ; Johnny Moretto [France] ; Perle Totoson [France] ; Daniel Wendling [France] ; Céline Demougeot [France] ; Nicolas Tordi [France] | Local cryotherapy improves adjuvant-induced arthritis through down-regulation of IL-6 / IL-17 pathway but independently of TNFα |
| 000299 (2016) |
C. Boin [France] ; S. Lambert [France] ; P. Thomann [France] ; O. Aujoulat [France] ; P. Kieffer [France] | [Castleman's disease: Rapid desensitization for hypersensitivity reaction to rituximab]. |
| 000325 (2016) |
Éric Toussirot [France] ; François Aubin [France] | Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview |
| 000351 (2016) |
C. Giraud [France] ; Z. Tatar [France] ; M. Soubrier [France] | Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis |
| 000365 (2015-06-10) |
V. Devauchelle [France] ; J.-M. Berthelot [France] ; D. Cornec [France] ; Y. Renaudineau [France] ; T. Marhadour [France] ; S. Jousse-Joulin [France] ; S. Querellou [France] ; F. Guarrigues ; M. De Bandt [France] ; M. Gouillou [France] ; A. Saraux [France] | FRI0280 Efficacy and Safety of Tocilizumab as First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study (Tenor) |
| 000369 (2015) |
A-P Trouvin ; S. Jacquot [France] ; S. Grigioni [France] ; E. Curis [France] ; I. Dedreux [France] ; A. Roucheux [France] ; H. Boulard ; O. Vittecoq [France] ; X. Le Loët ; O. Boyer [France] ; V. Goëb [France] | Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study |
| 000405 (2015) |
Michael Schiff [États-Unis] ; Bernard Combe [France] ; Thomas Dörner [Allemagne] ; Joel M. Kremer [États-Unis] ; Thomas W. Huizinga [Pays-Bas] ; Melissa Veenhuizen [États-Unis] ; Anne Gill [États-Unis] ; Wendy Komocsar [États-Unis] ; Pierre-Yves Berclaz [Japon] ; Robert Ortmann [États-Unis] ; Chin Lee [États-Unis] | Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study |
| 000535 (2013) |
S. Godot [France] ; J. E. Gottenberg [France] ; S. Paternotte ; I. Pane [France] ; B. Combe [France] ; J. Sibilia [France] ; R.-M. Flipo ; T. Schaeverbeke ; P. Ravaud [France] ; E. Toussirot ; F. Berenbaum [France] ; X. Mariette [France] ; D. Wendling ; J. Sellam [France] | THU0122 Safety of surgery in patients with rheumatoid arthritis treated by rituximab in routine care: Data from the french air registry |
| 000545 (2013) |
J. Mélet ; D. Mulleman ; P. Goupille ; B. Ribourtout [France] ; H. Watier [France] ; G. Thibault [France] | SAT0102 Rituximab-Induced T-Cell Depletion in Patients with Rheumatoid Arthritis: Association With Clinical Response |
| 000557 (2013) |
K. Sacre [France] ; M. Dehoux [France] ; M. Chauchard [France] ; D. Gobert [France] ; E. Pasqueloni [France] ; C. Compain [France] ; J.-F. Alexandra [France] ; M.-P. Chauveheid [France] ; O. Lidove [France] ; R. Roussel [France] ; T. Papo [France] | FRI0546 Pituitary-adrenal function after prolonged glucocorticoid therapy in systemic disorders |
| 000558 (2013) |
C. Gaujoux-Viala [France] ; L. Gossec [France] ; M. Dougados [France] ; B. Fautrel [France] | FRI0415 Being younger and living with a partner are important determinants of sustained favorable outcome in early arthritis (EA): Results from the french espoir cohort |
| 000559 (2013) |
A. Meyer [France] ; G. Lefevre ; A. Tournadre ; B. Le Goff ; S. Ottaviani [France] ; A.-L. Buchdahl ; M. De Brandt [France] ; P. Coquerelle [France] ; R.-M. Flipo ; G. Falgarone [France] ; G. Bernard [France] ; Z. Amoura [France] ; O. Benveniste [France] ; J. Sibilia [France] ; E. Hachulla ; B. Hervier [France] | FRI0381 During antisynthetase syndrome, anti-citrullinated peptides are a marker of severe joint disease |
| 000563 (2013) |
J. Morel [France] ; M. O. Duzanski [France] ; A. Cantagrel [France] ; B. Combe [France] ; M. Dougados [France] ; R. M. Flipo ; J. E. Gottenberg [France] ; X. Mariette [France] ; O. Vittecoq ; A. Saraux ; T. Schaeverbeke ; T. Bardin [France] ; M. Soubrier ; P. Ravaud [France] ; J. Siblia [France] | FRI0245 Prospective follow-up of tocilizumab treatment in 1100 patients with refractory rheumatoid arthritis: tolerance data from the french registry regate (registry –roactemra) |
| 000564 (2013) |
J. S. Smolen [Autriche] ; J. Wollenhaupt [Allemagne] ; P. Durez [Belgique] ; J. Gomez-Reino [Espagne] ; W. Grassi [Italie] ; M. Le Bars [France] ; C. Gaillez [France] ; C. Poncet [France] ; R. Westhovens [Belgique] | FRI0242 Time to achieve remission and sustained remission for mtx-naïve patients with early ra treated with abatacept plus mtx versus mtx alone in the agree trial |
| 000565 (2013) |
H. Nü Lein ; R. Alten [Allemagne] ; M. Galeazzi [Italie] ; H. M. Lorenz [Allemagne] ; D. Boumpas [Grèce] ; M. T. Nurmohamed [Pays-Bas] ; W. G. Bensen [Canada] ; G. R. Burmester [Allemagne] ; H.-H. Peter [Allemagne] ; F. Rainer [Autriche] ; K. Pavelka [République tchèque] ; M. Chartier ; C. Poncet [France] ; C. Rauch [Allemagne] ; M. Le Bars [France] | FRI0235 Adherence to the recommended dosing regimen of abatacept: results from the international, real-world action study |
| 000567 (2013) |
C. I. Daien ; S. Gailhac ; T. Mura [France] ; B. Combe ; M. Hahne ; J. Morel | FRI0221 Tocilizumab increases regulatory t cells and nk cells cytotoxicity in rheumatoid arthritis patients |
| 000569 (2013) |
P. Emery [Royaume-Uni] ; R. Westhovens [Belgique] ; M. Dougados [France] ; R. Alten [Allemagne] ; C. Gaillez ; C. Poncet [France] ; M. Le Bars ; A. Elegbe ; H. Genant [États-Unis] | FRI0199 In patients with established RA, abatacept efficacy is independent of baseline annual radiographic progression rate |
| 000570 (2013) |
M. Kostine ; T. Barnetche ; E. Ardouin ; M. Joly [France] ; E. Rabois [France] ; B. Glace [France] ; T. Schaeverbeke ; C. Richez | FRI0192 Is early neutropenia associated with clinical response in patients receiving tocilizumab in rheumatoid arthritis? |
| 000573 (2013) |
I. Castrejon [États-Unis] ; T. Pincus [États-Unis] ; M. Soubrier [France] ; Y. C. Lin [États-Unis] ; M. Dougados [France] | FRI0077 Relative efficiencies of joint counts and laboratory tests are no higher than patient-reported measures to document superior results in the guepard tight-control versus espoir routine care cohorts |
| 000585 (2013) |
E. Keystone [Canada] ; S. B. Cohen [États-Unis] ; P. Emery [Royaume-Uni] ; J. M. Kremer [États-Unis] ; M. Dougados [France] ; J. E. Loveless ; C. Chung [États-Unis] ; P. Wong [États-Unis] ; P. B. Lehane [Royaume-Uni] ; H. Tyrrell [Royaume-Uni] | AB0526 Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors in the reflex study |
| 000589 (2013) |
M. Couderc [France] ; S. Mathieu [France] ; M. Soubrier [France] | AB0310 Predictive factors for the response to rituximab in rheumatoid arthritis: Results from a french university hospital |
| 000592 (2013) |
A. Gardette ; S. Ottaviani ; F. Tubach ; P. Nicaise-Roland [France] ; E. Palazzo ; G. Gill ; O. Meyer ; P. Dieudé | AB0298 High level of anti-ccp antibodies is predictive of good response to rituximab in patients with active rheumatoid arthritis. |
| 000618 (2012) |
Fernando Kemta Lekpa [France] ; Cécile Poulain [France] ; Daniel Wendling [France] ; Martin Soubrier [France] ; Michel De Bandt [France] ; Jean Marie Berthelot [France] ; Philippe Gaudin [France] ; Eric Toussirot [France] ; Philippe Goupille [France] ; Thao Pham [France] ; Jérémie Sellam [France] ; Rémy Bruckert [France] ; Muriel Paul [France] ; Valérie Farrenq [France] ; Pascal Claudepierre [France] | Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study |
| 000660 (2011) |
Aurore Muselier [France] ; Philip Bielefeld ; Samuel Bidot ; Julien Vinit ; Jean-François Besancenot ; Alain Bron | Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis. |
| 000666 (2011) |
Joseph Paquet [France] ; Christel Henrionnet [France] ; Astrid Pinzano [France] ; Jean-Baptiste Vincourt [France] ; Pierre Gillet [France] ; Patrick Netter [France] ; Isabelle Chary-Valckenaere [France] ; Damien Loeuille [France] ; Jacques Pourel [France] ; Laurent Grossin [France] | Alternative for Anti-TNF Antibodies for Arthritis Treatment |
